The China Blended Cap ETF market saw a positive performance of 1.11% on June 15, 2023. This market, valued at 14 Bn EUR and consisting of 63 ETFs, reflected an overall upward trend fueled by the daily returns of some of its top ETFs. Notably, the iShares China Large Cap UCITS ETF (FXC) saw a daily return of 3.25%, followed by the JPMorgan ETFs (Ireland) ICAV - Carbon Transition China Equity (CTB) UCITS ETF (JCCT) at 2.68% and the KraneShares MSCI All China Health Care Index UCITS ETF (KURE) at 1.99%. The HSBC MSCI CHINA A UCITS ETF (HMCA) also made gains with a daily return of 0.30%.

The daily returns of these ETFs were in turn driven by the performance of several tech and healthcare companies in the market, including AMPEREX TECH ORD A (300750) with a 8.19% daily return and 10.99% over one week, MOUTAI ORD A (600519) with a 1.63% daily return and 5.22% over one week, MERCHANTS BANK ORD A (600036) with a 0.99% daily return, and CN PING AN ORD A (601318) with a 0.77% daily return. Overall, it appears that the China Blended Cap ETF market is benefiting from growth in various sectors, particularly in tech and healthcare.

See how over 500 professional investors use ETFs in the 2023 Trackinsight Global ETF Survey. Get access today.